(4-{[(tert-butoxycarbonyl)(methyl)amino]methyl}phenyl)boronic acid, 95.0%, 250mg

(3aS,8aS)-2,2-Dimethyl-4,4,8,8-tetra(naphthalen-2-yl)tetrahydro-[1,3]dioxolo[4,5-e][1,3,2]dioxaphosphepine 6-oxide, 98%, 50mg

(S)-2-m-Tolyl-propionic acid, 95.0%, 100mg

N1-Butylethane-1,2-diamine, 95.0%, 5g

1H-Pyrazole-1-carboxylic acid, 3-[bis[(1,1-dimethylethoxy)carbonyl]amino]-5-(1-hydroxyethyl)-, 1,1-dimethylethyl ester, 95%, 100mg

exo-Tetrahydrodicyclopentadiene>94.0%(GC)5g

3,4-Dimethylisoxazol-5-amine, 97.0%, 100mg

4-[(2-isopropylphenyl)amino]-4-oxobutanoic acid, 95.0%, 5g

2,3-Dimethylphenoxyacetic acid, 98.0%, 25g

(S)-(1-Fmoc-piperidin-2-yl)acetic acid, 99.0%, 250mg

4-Chloro-1H-pyrrolo[2,3-c]pyridine, 95.0%, 5g

(1R,3S)-3-Aminocyclopentanol hydrochloride, 97.0%, 5g

Fluoruro de tetrabutilamonio, 1 mol/l en THF, stab., 25 ml, envase de vidrio